In Vitro Conditioning of Adipose-Derived Mesenchymal Stem Cells by the Endothelial Microenvironment: Modeling Cell Responsiveness towards Non-Genetic Correction of Haemophilia A

被引:7
作者
Barbon, Silvia [1 ,2 ]
Stocco, Elena [1 ,2 ]
Rajendran, Senthilkumar [3 ]
Zardo, Lorena [4 ]
Macchi, Veronica [1 ]
Grandi, Claudio [2 ]
Tagariello, Giuseppe [4 ]
Porzionato, Andrea [1 ,2 ]
Radossi, Paolo [4 ]
De Caro, Raffaele [1 ,2 ]
Parnigotto, Pier Paolo [2 ]
机构
[1] Univ Padua, Sect Human Anat, Dept Neurosci, I-35121 Padua, Italy
[2] Fdn Biol & Regenerat Med Tissue Engn & Signaling, I-35030 Padua, Italy
[3] Univ Padua, Dept Surg Oncol & Gastroenterol, I-35124 Padua, Italy
[4] Castelfranco Veneto Hosp, Haematol & Haemophilia Ctr, I-31033 Castelfranco Veneto, Italy
关键词
adipose-derived stem cells; Haemophilia A; coagulation factor VIII; endothelial differentiation; stem cell therapy; regenerative medicine; GENE-THERAPY; PHENOTYPIC CORRECTION; PROGENITOR CELLS; TISSUE; TRANSPLANTATION; EXPRESSION; DIFFERENTIATION; CHONDROCYTES; MARKER;
D O I
10.3390/ijms23137282
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In recent decades, the use of adult multipotent stem cells has paved the way for the identification of new therapeutic approaches for the treatment of monogenic diseases such as Haemophilia A. Being already studied for regenerative purposes, adipose-derived mesenchymal stem cells (Ad-MSCs) are still poorly considered for Haemophilia A cell therapy and their capacity to produce coagulation factor VIII (FVIII) after proper stimulation and without resorting to gene transfection. In this work, Ad-MSCs were in vitro conditioned towards the endothelial lineage, considered to be responsible for coagulation factor production. The cells were cultured in an inductive medium enriched with endothelial growth factors for up to 21 days. In addition to significantly responding to the chemotactic endothelial stimuli, the cell populations started to form capillary-like structures and up-regulated the expression of specific endothelial markers (CD34, PDGFR alpha, VEGFR2, VE-cadherin, CD31, and vWF). A dot blot protein study detected the presence of FVIII in culture media collected from both unstimulated and stimulated Ad-MSCs. Remarkably, the activated partial thromboplastin time test demonstrated that the clot formation was accelerated, and FVIII activity was enhanced when FVIII deficient plasma was mixed with culture media from the untreated/stimulated Ad-MSCs. Overall, the collected evidence supported a possible Ad-MSC contribution to HA correction via specific stimulation by the endothelial microenvironment and without any need for gene transfection.
引用
收藏
页数:15
相关论文
共 63 条
[1]   CD271 as a marker to identify mesenchymal stem cells from diverse sources before culture [J].
Alvarez-Viejo, Maria ;
Menendez-Menendez, Yolanda ;
Otero-Hernandez, Jesus .
WORLD JOURNAL OF STEM CELLS, 2015, 7 (02) :470-476
[2]   Why is AAV FVIII gene therapy not approved by the US Food and Drug Administration yet? [J].
Arruda, Valder R. .
BLOOD ADVANCES, 2021, 5 (20) :4313-4313
[3]   Growth and Differentiation of Circulating Stem Cells After Extensive Ex Vivo Expansion [J].
Barbon, Silvia ;
Rajendran, Senthilkumar ;
Bertalot, Thomas ;
Piccione, Monica ;
Gasparella, Marco ;
Parnigotto, Pier Paolo ;
Di Liddo, Rosa ;
Conconi, Maria Teresa .
TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2021, 18 (03) :411-427
[4]   Biofabrication of a novel leukocyte-fibrin-platelet membrane as a cells and growth factors delivery platform for tissue engineering applications [J].
Barbon, Silvia ;
Stocco, Elena ;
Grandi, Francesca ;
Rajendran, Senthilkumar ;
Borean, Alessio ;
Pirola, Ivan ;
Capelli, Stefano ;
Bagno, Andrea ;
Tavano, Regina ;
Contran, Martina ;
Macchi, Veronica ;
De Caro, Raffaele ;
Parnigotto, Pier Paolo ;
Porzionato, Andrea ;
Grandi, Claudio .
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2018, 12 (08) :1891-1906
[5]   Reporting of activated partial thromboplastin time (aPTT): Could we achieve better comparability of the results? [J].
Bronic, Ana ;
Margetic, Sandra ;
Herak, Desiree Coen ;
Milic, Marija ;
Kresic, Branka ;
Biljak, Vanja Radisic ;
Krleza, Jasna Lenicek .
BIOCHEMIA MEDICA, 2021, 31 (02)
[6]   A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice [J].
Brown, Brian D. ;
Cantore, Alessio ;
Annoni, Andrea ;
Sergi, Lucia Sergi ;
Lombardo, Angelo ;
Della Valle, Patrizia ;
D'Angelo, Armando ;
Naldini, Luigi .
BLOOD, 2007, 110 (13) :4144-4152
[7]   A Molecular Revolution in the Treatment of Hemophilia [J].
Butterfield, John S. S. ;
Hege, Kerry M. ;
Herzog, Roland W. ;
Kaczmarek, Radoslaw .
MOLECULAR THERAPY, 2020, 28 (04) :997-1015
[8]   Current and emerging factor VIII replacement products for hemophilia A [J].
Cafuir, Lorraine A. ;
Kempton, Christine L. .
THERAPEUTIC ADVANCES IN HEMATOLOGY, 2017, 8 (10) :303-313
[9]   Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo [J].
Cao, Y ;
Sun, Z ;
Liao, LM ;
Meng, Y ;
Han, Q ;
Zhao, RCH .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 332 (02) :370-379
[10]   Progenitor Cells Identified by PDGFR-Alpha Expression in the Developing and Diseased Human Heart [J].
Chong, James J. H. ;
Reinecke, Hans ;
Iwata, Mineo ;
Torok-Storb, Beverly ;
Stempien-Otero, April ;
Murry, Charles E. .
STEM CELLS AND DEVELOPMENT, 2013, 22 (13) :1932-1943